
RecombinantCCL5(Rantes)
CatalogNo.Size#1112Anti-HIVCo-ReceptorCCR5Antibody50181P-22ug
50181P-1010ug
50181P-5050ug
50181P-100100ug
50181P-10001000ug
CCL5,alsoknownasRegulatedonActivation,NormalT-cellExpressedandSecreted(RANTES),isaproinflammatorychemokinethatinducesmigrationandactivationofleukocytes,andisalsoimpliedinHIVinfection.CCL5bindstocellsurfacereceptorsCCR1,CCR3,CCR4,andCCR5.
ItsBIOLOGicaleffectsonleukocyteactivationandHIVinfectionsisdependentuponconcentrationandonthebindingofcellsurfaceglycosaminoglycans.
DESCRIPTIONDESCRIPTIONSource:RecombinanthumanCCL5,producedinE.coli,correspondstoaa24-91(accessionno.P13501).
ProteinSequence:SPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS
MolecularMass:7.851kDabyMassSpec.
Purity:>97%
Activity:EC50=0.13nMdeterminedbyMigrationAssayinL1.2cellsexpressingCCR5.
EndotoxinLevel:<0.01EUper1ugofproteinbyLALmethod.
Form:Lyophilized.
CarrierProtein:None.
Reconstitution:Recommendedat100ug/mlinsteriledistilledwater.
StABIlityandStorage:12monthsfromdateofreceipt,-20oCto-70oC,assupplied.
1month,2oCto8oC,understerileconditionsafterreconstitution.
3months,-20oCto-70oC,understerileconditionsafterreconstitution.
Forinvitroinvestigationaluseonly.Notforuseindiagnosticortherapeuticprocedures.